Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease

ISSN： 0257-277X

Source： Immunologic Research, Vol.39, Iss.1-3, 2007-11, pp. : 225-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein

By Hansson M. Ringdahl J. Robert A. Power U. Goetsch L. Ngoc Nguyen T. Uhlen M. Stahl S. Nygren P.-A.

Immunotechnology, Vol. 4, Iss. 3, 1999-03 ,pp. : 237-252

Elsevier

Access to resources Recommend Favorite

Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity

Current Molecular Medicine, Vol. 13, Iss. 7, 2013-08 ,pp. : 1122-1139

Bentham Science Publishers

Access to resources Recommend Favorite

Respiratory Syncytial Virus—A Comprehensive Review

By Borchers Andrea Chang Christopher Gershwin M. Gershwin Laurel

Clinical Reviews in Allergy and Immunology, Vol. 45, Iss. 3, 2013-12 ,pp. : 331-379

Humana Press, Inc

Access to resources Recommend Favorite

Immune monitoring of children with respiratory syncytial virus infection

By Mejias Asuncion Hall Mark W Ramilo Octavio

Expert Review of Clinical Immunology, Vol. 9, Iss. 5, 2013-05 ,pp. : 393-395

Informa Healthcare

Access to resources Recommend Favorite

Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin

By Xu Z. Kuang M. Okicki J.R. Cramer H. Chaudhary N.

Antiviral Research, Vol. 61, Iss. 3, 2004-03 ,pp. : 195-206

Elsevier

Access to resources Recommend Favorite